Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …

Importance Large cohorts of patients with active cancers and COVID-19 infection are
needed to provide evidence of the association of recent cancer treatment and cancer type …

The SARS-CoV-2 pandemic significantly affected oncology practice across the globe. There
is uncertainty as to the contribution of patients' demographics and oncologic features to …

Aim of the study Patients with cancer might have an increased risk for severe outcome of
coronavirus disease 2019 (COVID-19). To identify risk factors associated with a worse …

Background Despite high contagiousness and rapid spread, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has led to heterogeneous outcomes across affected …

Introduction Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to
be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from …

Background Individuals with cancer, particularly those who are receiving systemic
anticancer treatments, have been postulated to be at increased risk of mortality from COVID …

Background Using an updated dataset with more patients and extended follow-up, we
further established cancer patient characteristics associated with COVID-19 death. Methods …

The SARS-Cov-2 pandemic in 2020 has caused oncology teams around the world to adapt
their practice in the aim of protecting patients. Early evidence from China indicated that …

Cancer patients are a vulnerable population postulated to be at higher risk for severe
coronavirus disease 2019 (COVID-19) infection. Increased COVID-19 morbidity and …